Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.
Published September 9, 2026 · Recall initiated: August 17, 2026
Summary
FDA records drug Class II recall D-0839-2026, published September 9, 2026 and initiated August 17, 2026. Recalling firm: Mylan Pharmaceuticals Inc; Status: Ongoing; Reported quantity: 47,662 bottles; Lot: Lot #: 3225272, Exp. September 30, 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
What to do
Voluntary: Firm initiated · Letter
Get an email if PRASUGREL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRASUGREL
- Manufacturer
- Mylan Pharmaceuticals Inc
- Distributor
- Nationwide within the U.S
- UPC
- 0303785185932
- Lot
- Lot #: 3225272, Exp. September 30, 2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDARevcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For IntramuscularSeptember 9, 2026
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDAPrasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,March 26, 2025
- FDAPRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDCMarch 26, 2025
- FDAPrasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WVNovember 6, 2019
Questions about this recall
Was Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93. recalled?
Yes. FDA published recall D-0839-2026 on September 9, 2026. Reported hazard: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.